SCHEMBL9102915

SCHEMBL9102915

Cc1cc(C(=O)N(C)[C@H](CN2CCCC2)C(C)C)ccc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9102926 1.00 — —
SCHEMBL9102798 0.99 — —
SCHEMBL9107134 0.91 SLC6A4 (0.54) —
SCHEMBL31478954 0.91 SLC6A4 (0.54) —
SCHEMBL9105618 0.91 SLC6A4 (0.54) —
SCHEMBL31478909 0.91 SLC6A4 (0.54) —
SCHEMBL9105610 0.91 SLC6A4 (0.54) —
SCHEMBL9102318 0.89 SLC6A4 (0.53) —
SCHEMBL31478874 0.89 SLC6A4 (0.53) —
SCHEMBL9105941 0.86 OPRK1 (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025082731-A1 INTRANASAL FORMULATIONS FOR TREATING OBSTRUCTIVE SLEEP APNEA MOSANNA THERAPEUTICS AG (CH) 2025-04-24 — — WO disclosed
US-20130143858-A1 COMPOUNDS AND THEIR USE AS IKACH BLOCKERS ASTRAZENECA AB (SE) 2013-06-06 — — US disclosed
US-8361998-B2 Compounds and their use as IKACh blockers ASTRAZENECA AB 2013-01-29 — — US disclosed
WO-2012074469-A1 NEW IKACH BLOCKERS ASTRAZENECA AB (SE) 2012-06-07 — — WO disclosed
US-20120142659-A1 COMPOUNDS AND THEIR USE AS IKACH BLOCKERS ASTRAZENECA AB (SE) 2012-06-07 — — US disclosed
Send feedback